Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02469389 · ClinicalTrials.gov registry record · NA

Improving Negative Symptoms & Community Engagement in Veterans With Schizophrenia

A NA study of Schizophrenia and Serious Mental Illness, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
105
Enrollment target
1
Study location

NCT02469389 is a NA study of Schizophrenia and Serious Mental Illness that has completed, run by VA Office of Research and Development. The registered enrollment target is 105 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02469389, a NA study of Schizophrenia and Serious Mental Illness, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
105 participants
Enrollment target
1
Study location

Study Summary

The goal of this project is to evaluate an innovative psychosocial intervention package that will incorporate evidence-based treatment strategies to target the affective-motivational deficits, negative expectancies, and behavioral skills deficits that are central to the maintenance of negative symptoms. The intervention - called EnCoRE (Engaging in Community Roles and Experiences) - will include strategies aimed at teaching Veterans with schizophrenia and negative symptoms ways to (1) overcome deficits in anticipatory pleasure, (2) increase intrinsic motivation for goal-directed activities, (3) reduce expectancies for failure, and (4) perform skillfully in new social situations, all of which can impact implementation of new skills and behaviors. Rather than develop a new set of intervention strategies, the investigators will include within EnCoRE evidence-based strategies for these treatment domains. In addition, the investigators will collect qualitative information both from Veterans concerning their perceptions of the strengths, weaknesses, and barriers to participation in EnCoRE, as well as from a sample of mental health providers who work with Veterans with schizophrenia and negative symptoms, in order to inform a larger scale implementation trial should EnCoRE prove effective here.

Interventions

  • BEHAVIORAL Health & Wellness (H&W)
  • BEHAVIORAL Engaging in Community Roles and Experiences (ENCoRE)

Study Locations (1)

Maryland

  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD - Baltimore

Trial Details

FieldValue
Enrollment Target 105 participants
Start Date 2015-08-03
Est. Completion 2020-05-27
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT02469389

The ClinicalTrials.gov registry entry for NCT02469389 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (52% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which Health & Wellness (H&W) is the first listed.

NCT02469389 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT02469389 about?

NCT02469389 is a clinical study titled "Improving Negative Symptoms & Community Engagement in Veterans With Schizophrenia". The goal of this project is to evaluate an innovative psychosocial intervention package that will incorporate evidence-based treatment strategies to target the affective-motivational deficits, negative expectancies, and behavioral skills deficits that are central to the maintenance of negative sympt...

What is the current status of trial NCT02469389?

This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2015-08-03. Estimated completion is 2020-05-27.

What conditions does trial NCT02469389 study?

This clinical trial studies the following conditions: Schizophrenia, Serious Mental Illness.

What interventions are being tested in trial NCT02469389?

The interventions under investigation include: Health & Wellness (H&W) (BEHAVIORAL), Engaging in Community Roles and Experiences (ENCoRE) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02469389?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02469389 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.